Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2021 Filed Dec 17, 2021 22:35 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 12,000 | $144.25 | $1,731,000.00 |
DisclosureSEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:35 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionCommon Stock | 12,000 | $18.86 | $226,320.00 |
DisclosureSEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 15, 2021 Filed Jan 27, 2022 23:21 UTC |
Carpenter RickChief Technical Officer
|
GrantRestricted Stock Unit · Derivative | 6,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000006 · wf-form4_164332569171949.xml · derivative · entry 1 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,495 Underlying: Common Stock · 6,495 shares Expires not disclosed F1 · security: Awarded on December 15, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company. F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionStock Option · Derivative | 286 | $82.34 Strike: $82.34 | $23,549.24 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · derivative · entry 5 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,601 Underlying: Common Stock · 286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionStock Option · Derivative | 797 | $89.54 Strike: $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · derivative · entry 4 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,514 Underlying: Common Stock · 797 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
SaleCommon Stock | 1,083 | $140.00 | $151,620.00 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · nonDerivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 286 | $82.34 | $23,549.24 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 797 | $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · derivative · entry 8 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 100 | $129.61 | $12,961.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 900 | $128.31 | $115,479.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,551 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $127.97 to $128.75. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 00:31 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionStock Option · Derivative | 238 | $82.34 Strike: $82.34 | $19,596.92 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · derivative · entry 10 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,148 Underlying: Common Stock · 238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionStock Option · Derivative | 1,667 | $51.50 Strike: $51.50 | $85,850.50 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · derivative · entry 9 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F10 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · derivative · entry 8 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097 Underlying: Common Stock · 310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 5 | $132.92 | $664.60 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 7 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,008 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 664 | $131.54 | $87,342.56 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 6 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,013 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $131.48 to $132.24.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 1,236 | $130.64 | $161,471.04 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 5 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,677 F3 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $130.19 to $131.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 238 | $82.34 | $19,596.92 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 4 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 1,667 | $51.50 | $85,850.50 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 3 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
Tax withholdingCommon Stock | 154 | $129.66 | $19,967.64 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,008 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 19:59 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000226 · wf-form4_163840673830554.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:34 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000218 · wf-form4_163840525190692.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,726 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:34 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 185 | $129.66 | $23,987.10 |
DisclosureSEC source: 0001438133-21-000218 · wf-form4_163840525190692.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:34 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000218 · wf-form4_163840525190692.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:40 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000222 · wf-form4_163840559597053.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,065 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:40 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 202 | $129.66 | $26,191.32 |
DisclosureSEC source: 0001438133-21-000222 · wf-form4_163840559597053.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,349 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:40 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000222 · wf-form4_163840559597053.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:42 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000224 · wf-form4_163840573447520.xml · derivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,197 Underlying: Common Stock · 820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:42 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 407 | $129.66 | $52,771.62 |
DisclosureSEC source: 0001438133-21-000224 · wf-form4_163840573447520.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,023 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:42 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000224 · wf-form4_163840573447520.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:31 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · derivative · entry 7 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,065 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:31 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Tax withholdingCommon Stock | 202 | $129.66 | $26,191.32 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:31 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:37 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000220 · wf-form4_163840544104382.xml · derivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,065 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:37 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 178 | $129.66 | $23,079.48 |
DisclosureSEC source: 0001438133-21-000220 · wf-form4_163840544104382.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,310 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:37 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000220 · wf-form4_163840544104382.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:28 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000214 · wf-form4_163840488795888.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,065 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:28 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 193 | $129.66 | $25,024.38 |
DisclosureSEC source: 0001438133-21-000214 · wf-form4_163840488795888.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,546 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:28 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000214 · wf-form4_163840488795888.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 21:46 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionStock Option · Derivative | 34,624 | $18.86 Strike: $18.86 | $653,008.64 |
DisclosureSEC source: 0001438133-21-000209 · wf-form4_163718553924452.xml · derivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 34,624 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 21:46 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
SaleCommon Stock | 34,624 | $142.21 | $4,923,712.84 |
DisclosureSEC source: 0001438133-21-000209 · wf-form4_163718553924452.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,082 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 6, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $142.00 to $142.68. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 21:46 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 34,624 | $18.86 | $653,008.64 |
DisclosureSEC source: 0001438133-21-000209 · wf-form4_163718553924452.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 16:35 UTC |
Leal JamesSVP, Operations
|
GrantCommon Stock | 101 | $69.39 | $7,008.39 |
DisclosureSEC source: 0001438133-21-000207 · wf-form4_163718493616315.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,852 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 18, 2021 through November 15, 2021. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionStock Option · Derivative | 4,874 | $82.34 Strike: $82.34 | $401,325.16 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · derivative · entry 5 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,887 Underlying: Common Stock · 4,874 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionStock Option · Derivative | 15,936 | $89.54 Strike: $89.54 | $1,426,909.44 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · derivative · entry 4 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,311 Underlying: Common Stock · 15,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
SaleCommon Stock | 21,785 | $140.02 | $3,050,407.59 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · nonDerivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $140.00 to $140.18. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 4,874 | $82.34 | $401,325.16 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 15,936 | $89.54 | $1,426,909.44 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:45 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 10,000 | $18.86 Strike: $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-21-000201 · wf-form4_163614513453049.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,160 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.